A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia
Clinical trial NCT07416032 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07416032
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-20
- Primary completion
- 2028-06-20
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.